Revenue | ₹412.59Cr |
Net Profits | ₹42.01Cr |
Net Profit Margins | 10.18% |
Cohance Lifesciences Ltd’s revenue jumped 52.82% since last year same period to ₹412.59Cr in the Q4 2024-2025. On a quarterly growth basis, Cohance Lifesciences Ltd has generated 27.79% jump in its revenue since last 3-months.
Cohance Lifesciences Ltd’s net profit fell -21.29% since last year same period to ₹42.01Cr in the Q4 2024-2025. On a quarterly growth basis, Cohance Lifesciences Ltd has generated -49.31% fall in its net profits since last 3-months.
Cohance Lifesciences Ltd’s net profit margin fell -48.49% since last year same period to 10.18% in the Q4 2024-2025. On a quarterly growth basis, Cohance Lifesciences Ltd has generated -60.34% fall in its net profit margins since last 3-months.
The revenue for Cohance Lifesciences Ltd in the Q4 results 2024 was ₹412.59Cr.
The net profit for Cohance Lifesciences Ltd in the Q4 results 2024 was ₹42.01Cr.
The net profit margin for Cohance Lifesciences Ltd in the Q4 results 2024 was 10.18%.
The revenue for Cohance Lifesciences Ltd in the Q4 results 2023 was ₹269.98Cr.
The net profit for Cohance Lifesciences Ltd in the Q4 results 2023 was ₹53.37Cr.
The net profit margin for Cohance Lifesciences Ltd in the Q4 results 2023 was 19.77%.